Therapeutic Asset Ratings
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Carboplatin
Fallopian Tube Carcinoma
Women's Hospital School Of Medicine Zhejiang University
P3
BBB
(72)
Carboplatin
Breast Carcinoma
RenJi Hospital
P3
BBB
(72)
Cediranib
Melanoma
M.D. Anderson Cancer Center
P3
BBB
(72)
CIS-DIAMMINEDICHLOROPLATINUM II
Urinary Bladder Carcinoma
G1 Therapeutics, Inc.
P3
BBB
(72)
Cyclophosphamide
Acute Promyelocytic Leukemia
Sumithira Vasu
P3
BBB
(72)
Cyclophosphamide
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
BGI, China
P3
BBB
(72)
Cyclophosphamide
Childhood Acute Myeloid Leukemia
Fred Hutchinson Cancer Center
P3
BBB
(72)
Cyclophosphamide
Myelodysplastic/Myeloproliferative Neoplasm
Prelude Therapeutics
P3
BBB
(72)
Cyclophosphamide
T-Cell And NK-Cell Neoplasm
New York Medical College
P3
BBB
(72)
Cyclophosphamide
Cancer Of Unknown Primary Site
M.D. Anderson Cancer Center
P3
BBB
(72)
CYCLOSPORIN A
Mantle Cell Lymphoma
Fred Hutchinson Cancer Center
P3
BBB
(72)
CYTARABINE
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
Novartis Pharmaceuticals
P3
BBB
(72)
CYTARABINE
Childhood Myelodysplastic Syndrome
Children's Oncology Group
P3
BBB
(72)
CYTARABINE
Myelodysplastic Syndrome With Excess Blasts
University of Southern California
P3
BBB
(72)
CYTARABINE
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)
P3
BBB
(72)
DACARBAZINE
Cutaneous Melanoma
Linnaeus Therapeutics, Inc.
P3
BBB
(72)
Daunorubicin
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)
P3
BBB
(72)
DEXAMETHASONE
Childhood Acute Lymphoblastic Leukemia
Tanja Andrea Gruber
P3
BBB
(72)
DEXAMETHASONE
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BBB
(72)
DEXAMETHASONE
Plasma Cell Neoplasm
Hellenic Society of Hematology
P3
BBB
(72)
Docetaxel
Prostate Adenocarcinoma
Instituto do Cancer do Estado de São Paulo
P3
BBB
(72)
Docetaxel
Squamous Cell Lung Carcinoma
Shanghai JMT-Bio Inc.
P3
BBB
(72)
DOXORUBICIN
B-Cell Adult Acute Lymphocytic Leukemia
Massachusetts General Hospital
P3
BBB
(72)
DOXORUBICIN
Nodular Lymphocyte Predominant Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BBB
(72)
DOXORUBICIN
Peritoneal Neoplasm
Eli Lilly and Company
P3
BBB
(72)
Showing 901 to 925 of 42,334 assets
Previous
Page 37 of 1694
Next